Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 35 results.
User Information
Export Records
  1. 1.   Inhibition of Osteogenic Differentiation of Human Adipose-Derived Stromal Cells by Retinoblastoma Binding Protein 2 Repression of RUNX2-Activated Transcription
  2. Ge, W. S.; Shi, L.; Zhou, Y. S.; Liu, Y. S.; Ma, G. E.; Jiang, Y.; Xu, Y. W.; Zhang, X.; Feng, H. L.
  3. Stem Cells. 2011, Jul; 29(7): 1112-1125.
  1. 2.   RNA polymerase III transcription in cancer: the BRF2 connection
  2. Cabarcas, S.; Schramm, L.
  3. Molecular Cancer. 2011, Apr; 10: 10.
  1. 3.   Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G(1)/S transition
  2. Li, W.; Kotoshiba, S.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(2): 486-491.
  1. 4.   Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms
  2. Satyanarayana, A.; Kaldis, P.
  3. Oncogene. 2009 28(33): 2925-2939.
  1. 5.   p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint
  2. Satyanarayana, A.; Hilton, M. B.; Kaldis, P.
  3. Molecular Biology of the Cell. 2008 19(1): 65-77.
  1. 6.   HGPRT mutation induction by N-ethyl-N-nitrosourea as measured by 6-thioguanine resistance is higher in male than in female Syrian hamster fetuses
  2. Donovan, P. J.; Smith, G. T.; Dove, L. F.; Klose, J.; Powell, D. A.
  3. Birth Defects Research Part B-Developmental and Reproductive Toxicology. 2006, Oct; 77(5): 399-404.
  1. 7.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 8.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 9.   P205, A potential, tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation
  2. Asefa, B.; Dermott, J. M.; Kaldis, P.; Stefanisko, K.; Garfinkel, D. J.; Keller, J. R.
  3. Febs Letters. 2006, Feb; 580(5): 1205-1214.
  1. 10.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 11.   C/EBP beta cooperates with RB : E2F to implement Ras(V12)-induced cellular senescence
  2. Sebastian, T.; Malik, R.; Thomas, S.; Sage, J.; Johnson, P. F.
  3. Embo Journal. 2005, SEP 21; 24(18): 3301-3312.
  1. 12.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 13.   Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer
  2. Kanao, H.; Enomoto, T.; Ueda, Y.; Fujita, M.; Nakashima, R.; Ueno, Y.; Miyatake, T.; Yoshizaki, T.; Buzard, G. S.; Kimura, T.; Yoshino, K.; Murata, Y.
  3. Cancer Letters. 2004, SEP 15; 213(1): 31-37.
  1. 14.   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
  2. Asefa, B.; Klarmann, K. D.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Keller, J. R.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 155-167.
  1. 15.   Inhibition of growth by p205: A nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation
  2. Dermott, J. M.; Gooya, J. M.; Asefa, B.; Weiler, S. R.; Smith, M.; Keller, J. R.
  3. Stem Cells. 2004 22(5): 832-848.
  1. 16.   Cdk2 knockout mice are viable
  2. Berthet, C.; Aleem, E.; Coppola, V.; Tessarollo, L.; Kaldis, P.
  3. Current Biology. 2003 13(20): 1775-1785.
  1. 17.   Regulation of the p53 pathway by Ras, the plot thickens
  2. McMahon, M.; Woods, D.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2001 1471(2): M63-M71.
  1. 18.   E2F-1 induced apoptosis
  2. Phillips, A. C.; Vousden, K. H.
  3. Apoptosis. 2001 6(3): 173-182.
  1. 19.   Functional interaction of bZIP proteins and the large subunit of replication factor C in liver and adipose cells
  2. Hong, S. H.; Park, S. J.; Kong, H. J.; Shuman, J. D.; Cheong, J. H.
  3. Journal of Biological Chemistry. 2001 276(30): 28098-28105.
  1. 20.   Nuclear membrane protein LAP2 beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less)
  2. Nili, E.; Cojocaru, G. S.; Kalma, Y.; Ginsberg, D.; Copeland, N. G.; Gilbert, D. J.; Jenkns, N. A.; Berger, R.; Shaklai, S.; Amariglio, N.; Brok-Simoni, F.; Simon, A. J.; Rechavi, G.
  3. Journal of Cell Science. 2001 114(18): 3297-3307.
  1. 21.   CAK-independent activation of CDK6 by a viral cyclin
  2. Kaldis, P.; Ojala, P. M.; Tong, L.; Makela, T. P.; Solomon, M. J.
  3. Molecular Biology of the Cell. 2001 12(12): 3987-3999.
  1. 22.   Workshop to identify critical windows of exposure for children's health: Cancer work group summary
  2. Olshan, A. F.; Anderson, L.; Roman, E.; Fear, N.; Wolff, M.; Whyatt, R.; Vu, V.; Diwan, B. A.; Potischman, N.
  3. Environmental Health Perspectives. 2000 108(Suppl 3): 595-597.
  1. 23.   Human papillomavirus and cancer: The viral transforming genes
  2. Phillips, A. C.; Vousden, K. H.; Newton, R.; Beral, V.; Weiss, R. A.
  3. Infections and Human Cancer. 1999; 33 : 55-74.
  1. 24.   E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
  2. Phillips, A. C.; Ernst, M. K.; Bates, S.; Rice, N. R.; Vousden, K. H.
  3. Molecular Cell. 1999 4(5): 771-781.
  1. 25.   P16/Cdkn2 Alterations and Prb Expression in Oesophageal Squamous Carcinoma
  2. Busatto, G.; Shiao, Y. H.; Parenti, A. R.; Baffa, R.; Ruol, A.; Plebani, M.; Rugge, M.
  3. Molecular Pathology. 1998 51(2): 80-84.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel